11/14/2024 3:03 PM | Aileron Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024 4:17 PM | Aileron Therapeutics (Subject) UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Filed by)
| Form SCHEDULE 13G/A | |
08/22/2024 3:05 PM | Aileron Therapeutics (Issuer) Musso Alan A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 3:06 PM | Aileron Therapeutics (Issuer) Ambros Reinhard J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 3:06 PM | Aileron Therapeutics (Issuer) Fairey William (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 3:07 PM | Aileron Therapeutics (Issuer) VON RICKENBACH JOSEF H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 3:09 PM | Aileron Therapeutics (Issuer) Aivado Manuel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
08/14/2024 4:12 PM | Aileron Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024 4:23 PM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2024 3:29 PM | Aileron Therapeutics (Filer)
| Form 424B5 | |
07/26/2024 3:33 PM | Aileron Therapeutics (Filer)
| Form 424B5 | |
07/26/2024 3:36 PM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/09/2024 7:41 AM | Aileron Therapeutics (Filer)
| Form ARS | |
07/09/2024 7:30 AM | Aileron Therapeutics (Filer)
| Form DEF 14A | |
07/09/2024 7:36 AM | Aileron Therapeutics (Filer)
| Form DEFA14A | |
06/17/2024 6:03 PM | Aileron Therapeutics (Issuer) UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 5:18 PM | Aileron Therapeutics (Issuer) UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 5:59 PM | Aileron Therapeutics (Issuer) UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 5:58 AM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/16/2024 4:19 PM | Aileron Therapeutics (Issuer) Cunningham Timothy M. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/15/2024 4:16 PM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 4:54 PM | Aileron Therapeutics (Issuer) UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4/A | |
05/01/2024 6:15 PM | Aileron Therapeutics (Issuer) UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2024 4:24 PM | Aileron Therapeutics (Filer)
| Form 424B5 | |
05/01/2024 4:25 PM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2024 4:16 PM | Aileron Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/01/2024 7:40 AM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2024 7:54 AM | Aileron Therapeutics (Subject)
| Form FWP | |
04/30/2024 2:32 PM | Aileron Therapeutics (Issuer) UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/29/2024 7:33 AM | Aileron Therapeutics (Filer)
| Form 10-K/A | |
04/16/2024 4:16 PM | Aileron Therapeutics (Subject) Satter Muneer A (Filed by)
| Form SC 13D/A | |
04/15/2024 4:21 PM | Aileron Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
04/15/2024 4:22 PM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 3:15 PM | Aileron Therapeutics (Issuer) Ambros Reinhard J. (Reporting)
| Form 4/A | |
04/10/2024 3:15 PM | Aileron Therapeutics (Issuer) VON RICKENBACH JOSEF H (Reporting)
| Form 4/A | |
04/02/2024 5:10 PM | Aileron Therapeutics (Issuer) Garner Charles (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/01/2024 3:15 PM | Aileron Therapeutics (Filer)
| Form NT 10-K | |
03/29/2024 7:03 AM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/15/2024 6:00 AM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 4:06 PM | Aileron Therapeutics (Issuer) WINDSOR JAMES BRIAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:14 PM | Aileron Therapeutics (Subject) UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO (Filed by)
| Form SC 13G | |
Download Our Tesla Ebook For Free (Ad) Like many of you, we here at the TradingPub are bullish on Tesla long term.
We believe the company will continue to be a leader in technology, EVs and A.I.
We also believe it’s share price will be rewarded in a big way…
In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. |
03/01/2024 3:05 PM | Aileron Therapeutics (Issuer) VON RICKENBACH JOSEF H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 3:05 PM | Aileron Therapeutics (Issuer) Ambros Reinhard J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 6:01 AM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 9:28 AM | Aileron Therapeutics (Subject) BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/13/2024 6:01 AM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2024 11:15 PM | Aileron Therapeutics (Filer)
| Form EFFECT | |
02/05/2024 12:20 PM | Aileron Therapeutics (Subject) Kapnick Scott (Filed by)
| Form SC 13G/A | |
01/29/2024 7:46 AM | Aileron Therapeutics (Filer)
| Form DEF 14A | |
01/29/2024 7:48 AM | Aileron Therapeutics (Filer)
| Form ARS | |
01/29/2024 7:14 AM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/25/2024 6:00 AM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 3:44 PM | Aileron Therapeutics (Filer)
| Form PRE 14A | |
01/11/2024 3:18 PM | Aileron Therapeutics (Filer)
| Form 8-K/A | |
01/10/2024 3:08 PM | Aileron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 4:56 PM | Aileron Therapeutics (Issuer) WINDSOR JAMES BRIAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 3:43 PM | Aileron Therapeutics (Issuer) WINDSOR JAMES BRIAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |